Why the study?
Does intravenous verapamil improve myocardial performance in patients with coronary artery disease without heart failure?
Does intravenous verapamil improve myocardial performance in patients with coronary artery disease without heart failure?
In patients with CAD without heart failure, intravenous verapamil improves overall cardiac function because its potent vasodilatory properties overcome its intrinsic negative inotropic effect.
No takes yet. Share an insight, caveat, or question.
Verapamil may improve LV performance in CAD without HF; leaves open need for RCTs before any practice change.
Ferlinz et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: